To hear about similar clinical trials, please enter your email below
Trial Title:
Reconstruction After Abdominoperineal Resection With Robot-assisted Harvest of VRAM Flap
NCT ID:
NCT05689775
Condition:
Perineum; Wound
Postoperative Complications
Rectal Neoplasms
Rectus Abdominis Hernia
Prospective Studies
Wound Heal
Sexual Health
Conditions: Official terms:
Rectal Neoplasms
Postoperative Complications
Wounds and Injuries
Conditions: Keywords:
Rectus abdominis muscle flap
Reconstruction
Perineum
Study type:
Observational [Patient Registry]
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Procedure
Intervention name:
Reconstruction with robot-assisted rectus abdominis muscle flap
Description:
Reconstruction of perineum and/or vagina with robot-assisted rectus abdominis muscle
flap.
Arm group label:
Patients
Summary:
Non-randomized study of robot-assisted perineal reconstruction with rectus abdominis
muscle flap in patients operated with abdominoperineal resection for irradiated locally
advanced rectal or anal cancer. Operative time, complications, wound healing, pre- and
postoperatively abdominal wall strength and patient related outcomes including sexual
health will be registered.
Detailed description:
Inclusion criteria:
Patients > 18 years of age operated with robotic-assisted abdominoperineal resection for
irradiated locally advanced rectal or anal cancer where robotic-assisted perineal and/or
vaginal reconstruction has been performed with a rectus abdominis muscle flap.
Methods Up to 40 patients operated with robotic-assisted abdominoperineal resection with
Da Vinci Xi surgical system (Intuitive Surgical, Sunnyvale, California, USA) and
robotic-assisted reconstruction with a pedicled rectus muscle will be included in this
prospective, non-randomized study.
In addition to the standardized post-operative care for patients with locally advanced
rectal or anal cancer as specified by national guidelines, patients will be offered
study-specific follow-up visits at 1, 6 and 12 months.
Complications are recorded by the accordion severity grading system of surgical
complications. Patient related outcomes measures will be registered by using European
organization for research and treatment of cancer Quality of life questionnaire Core 30
(EORTC QLQ-C30). Sexual health will be registered by a subset of questions from European
organization for research and treatment of cancer Quality of life questionnaire Sexual
health (EORTC QLQ-SH22).
Primary endpoint:
- perineal wound healing at 3 months
Secondary endpoints:
- early (< 30 days) and late (> 30 days) complications
- quality of life preoperatively and at 3- and 12 months postoperatively
- sexual function preoperatively and at 3- and 12 months postoperatively
- clinical evaluation of abdominal wall strength preoperatively, at 3- and 12 months
postoperatively
Criteria for eligibility:
Study pop:
Patients with rectal or anal cancer who are scheduled for robot-assisted abdominoperineal
resection who need reconstruction of pelvic floor and/or vagina with rectus abdomens
muscle flap.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- patients with rectal or anal cancer
- scheduled for robot-assisted abdominoperineal resection
- reconstruction of pelvic floor and/or vagina with rectus abdominis muscle flap
Exclusion Criteria:
- patients not eligible for robot-assisted procedure
- rectus abdominis muscle not available for harvest
- the expected wound defect is not suitable for reconstruction with rectus abdominis
muscle flap
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Oslo University Hospital, Radiumhospitalet
Address:
City:
Oslo
Zip:
0424
Country:
Norway
Status:
Recruiting
Contact:
Last name:
Lars Frich, MD, PhD
Phone:
004722930000
Email:
lfrich@ous-hf.no
Start date:
September 1, 2022
Completion date:
December 31, 2026
Lead sponsor:
Agency:
Oslo University Hospital
Agency class:
Other
Source:
Oslo University Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05689775